Dr. Philip Awadalla is the National Co-Scientific Director at CanPath, a Senior Professor of Molecular Genetics at the University of Oxford and a Professor at the University of Toronto. Previously, as Director of Computational Biology at the Ontario Institute of Cancer Research, he advanced early cancer detection and precision oncology, focusing on clonal hematopoiesis, breast, and prostate cancer. His research on rare mutations has informed disease susceptibility in cancer, psychiatric conditions, and aging. Early work in malaria resulted in the first global maps of malaria genome diversity leading to discoveries on how humans and pathogens co-evolve. His lab aims to identify early cellular and environmental determinants of aging and cancers using genomic, imaging and advanced AI approaches. He serves on key committees, including the International Health Cohort Consortium Steering Committee and advisory boards for the NIH-NIEHS, European Genome Archive, and NIH/Wellcome Trust’s H3Africa program.